{"DataElement":{"publicId":"3040382","version":"1","preferredName":"Radiolabeled Monoclonal Antibody Preparative Regimen Plan Administration Total Medication Dose Integer::1 Decimal Place Value","preferredDefinition":"The 1 decimal place numeric value measured, assigned or computed related to the planned total dosage of the radiolabeled monoclonal antibody preparative regimen that was administered.","longName":"2741560v1.0:3040321v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2741560","version":"1","preferredName":"Radiolabeled Monoclonal Antibody Preparative Regimen Plan Administration","preferredDefinition":"Any compound that has been joined with a radioactive substance._An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment._The chemotherapy and/or radiation given to blood, marrow or cord blood transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur._To devise, contrive, or formed in design._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","longName":"RMAB_PRP_RG_PLN_ADMN","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2741519","version":"1","preferredName":"Radiolabeled Monoclonal Antibody Preparative Regimen","preferredDefinition":"Any compound that has been joined with a radioactive substance.:An antibody produced by a clone or genetically homogenous population of hybrid cells i.e., hybridoma; hybrid cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis and treatment.:The chemotherapy and/or radiation given to bone marrow transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur.","longName":"C18138:C20401:C61155","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiolabeled","conceptCode":"C18138","definition":"Any compound that has been joined with a radioactive substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Monoclonal Antibody","conceptCode":"C20401","definition":"An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preparative Regimen","conceptCode":"C61155","definition":"The chemotherapy or radiation given prior to blood, marrow, cord blood transplant, or cell infusion to kill diseased cells and make space for the healthy new graft and/or suppress the immune system so rejection does not occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AEC075A-459B-26F2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-04-15","modifiedBy":"ONEDATA","dateModified":"2008-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2671279","version":"1","preferredName":"Planned Administration","preferredDefinition":"Planned; devised, contrived, or formed in design.:The act of administration.","longName":"C25619:C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plan","conceptCode":"C25619","definition":"To devise, contrive, or form in design.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"374709E4-7E6C-535B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-09","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-09","modifiedBy":"ONEDATA","dateModified":"2007-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AEB8861-9842-3E4B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-04-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":". Updated def for prep reg, no version needed. AK 12/20/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3040321","version":"1","preferredName":"Total Medication Dose 1 Decimal Place Value","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._A drug or medicine that treats or prevents or alleviates the symptoms of disease._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._A number with no fractional part, including the negative and positive numbers as well as zero.::1_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"3040321v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6774938","version":"1","preferredName":"Total Medication Dose Integer::1 Decimal Place Value","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.:A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.:A number with no fractional part, including the negative and positive numbers as well as zero.::1:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"6774938v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A97929F-9858-6527-E053-F662850AFC32","latestVersionIndicator":"Yes","beginDate":"2019-06-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-05","modifiedBy":"ONEDATA","dateModified":"2019-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"832E0F1E-E0C1-CDED-E040-BB89AD434116","latestVersionIndicator":"Yes","beginDate":"2010-04-01","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-04-01","modifiedBy":"KUMMEROA","dateModified":"2019-06-05","changeDescription":"2010-06-17: Added the missing concept for \"Decimal Place\" in the representation term, long name, and definition. Updated the decimal place - RA","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964924","version":"1","longName":"2400r1: Pre-TED","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"pre_ted_pre_oth_rmab_dose","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_prep_bexxar_dose","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_prep_ibrtmab_dose","type":"NMDP_FN","context":"NHLBI"},{"name":"DefinedSubstanceAdministration:periodProductDoseTotal","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the planned total do","type":"Preferred Question Text","description":"What was the planned total dosage of the radiolabeled monoclonal antibody preparative regimen?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:3040382","type":"BRIDG Mapping Path","description":"PerformedSubstanceAdministration > PlannedActivity > StudyActivity > DefinedSubstanceAdministration.periodProductDoseTotal.PQ.value WHERE DefinedProcedure > Material.Product.typeCode = \"Radio Labeled\" AND Product.classCode = \"monoclonal antibody\" AND PerformedSubstanceAdministration > DefinedSubstanceAdministration > DefinedCompositionRelationship > DefinedSubjectActivityGroup.nameCode = \"Perform preparative regimen\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"832E922F-7208-5B88-E040-BB89AD435D60","latestVersionIndicator":"Yes","beginDate":"2010-04-01","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-04-01","modifiedBy":"KUMMEROA","dateModified":"2021-08-05","changeDescription":"2021-8-5 ak System generated def displayed as alt def. 2010-06-17:Added the missing concept for \"Decimal Place\" in the long name, and definition - RA","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}